Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer

December 06, 2023 00:21:52
Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer
COR2ED - Oncology Medical Conversation
Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer

Dec 06 2023 | 00:21:52

/

Show Notes

Dr. Jaume Capdevila, a Medical Oncologist at Vall d’Hebron University Hospital in Barcelona, Spain, and Dr. Rachel van Leeuwaarde, an Endocrinologist from the University Medical Center of Utrecht in The Netherlands discuss the use of multi-kinase inhibitors (MKIs), in particular VEGFR-TKIs in patients with radioactive iodine refractory differentiated thyroid cancer (DTC).

In this podcast, the two experts discuss key trials (SELECT, DECISION and COSMIC-311) and efficacy parameters of the current VEGFR-TKIs (lenvatinib, sorafenib and cabozantinib), how to manage toxicity whilst trying to optimise treatment outcomes and preserving always patients’ quality of life. They also discuss treatment strategies, when to start systemic treatment, which drug should be used first and how to sequence therapies. To close the podcast they take a look at ongoing clinical trials with other treatments in development for DTC.

Other Episodes

Episode

December 06, 2023 00:20:49
Episode Cover

RCC: Treating advanced RCC - The role of VEGFR-TKIs alone or in combination therapy

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Prof. Georg Hutterer, a Urologist from the Medical University of...

Listen

Episode

December 06, 2023 00:22:00
Episode Cover

GI cancer: Management of skin toxicity from multikinase inhibitors

In this podcast, Beth Wittmer RN, Director of Care Management at Florida Cancer Specialists, USA and Prof. Hans Prenen, GI Medical Oncologist from Antwerp...

Listen

Episode

December 06, 2023 00:27:20
Episode Cover

Managing thrombosis: Part 2 - Cancer and thrombosis

In this podcast episode, Prof Dimitrios Tsakiris (Haematologist, Basel University, Switzerland) and Dr Lars Asmis (Haematologist, University of Zurich, Switzerland) discuss the association between...

Listen